Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cell Death Discovery|June 17, 2022
Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer managementYihao Liao, Diansheng Zhou, Pu Wang, et al.Cancer Letters|December 7, 2021
Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?Yihao Liao, Mengyue Yang, Keke Wang, et al.Journal of Clinical Laboratory Analysis|March 29, 2021
The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta-analysisYihao Liao, Huiqin Tang, Miaomiao Wang, et al.Frontiers in Immunology|August 8, 2026
Decoding benign prostatic hyperplasia at single-cell resolution: heterogeneity, inflammation, and beyond androgen-driven pathogenesisYihao Liao, Siyuan Jiang, Haohan Wang, et al.Frontiers in Oncology|May 25, 2026
The deubiquitinase USP35: from an oncogenic hub to a therapeutic target in human cancersBisheng Li, Yuhong Wen, Rubin Wang, et al.Cell Death & Disease|September 22, 2022
Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancerNing Wu, YouZhi Wang, KeKe Wang, et al.Apoptosis : an International Journal on Programmed Cell Death|March 31, 2023
MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinomaBoqiang Zhong, Youzhi Wang, Yihao Liao, et al.Journal of Cancer|August 18, 2021
Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancerYihao Liao, Xuanxuan Zou, Keke Wang, et al.Neuroreport|September 27, 2022
Ferroptosis involved in sevoflurane-aggravated young rats brain injury induced by liver transplantationXi Yu, Xiaoyan Ma, Jingshu Lyu, et al.Frontiers in Genetics|September 19, 2022
Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic studyYouZhi Wang, Ning Wu, KeKe Wang, et al.Pageof 2